Literature DB >> 30848692

Histological Criteria that Distinguish Human and Mouse Bone Formed Within a Mouse Skeletal Repair Defect.

Xiaonan Xin1, Xi Jiang1, Liping Wang1, Paiyz Mikael2, Mary Beth McCarthy2, Li Chen1, Augustus D Mazzocca2, Syam Nukavarapu2,3, Alexander C Lichtler1, David W Rowe1.   

Abstract

The effectiveness of autologous cell-based skeletal repair continues to be controversial in part because in vitro predictors of in vivo human bone formation by cultured human progenitor cells are not reliable. To assist in the development of in vivo assays of human osteoprogenitor potential, a fluorescence-based histology of nondecalcified mineralized tissue is presented that provides multiple criteria to distinguish human and host osteoblasts, osteocytes, and accumulated bone matrix in a mouse calvarial defect model. These include detection of an ubiquitously expressed red fluorescent protein reporter by the implanted human cells, antibodies specific to human bone sialoprotein and a human nuclear antigen, and expression of a bone/fibroblast restricted green fluorescent protein reporter in the host tissue. Using low passage bone marrow-derived stromal cells, robust human bone matrix formation was obtained. However, a striking feature is the lack of mouse bone marrow investment and osteoclasts within the human bone matrix. This deficiency may account for the accumulation of a disorganized human bone matrix that has not undergone extensive remodeling. These features, which would not be appreciated by traditional decalcified paraffin histology, indicate the human bone matrix is not undergoing active remodeling and thus the full differentiation potential of the implanted human cells within currently used mouse models is not being realized.

Entities:  

Keywords:  GFP; RFP; bone cell transplantation; bone matrix; calvarial defect model; cryohistology; epifluorescence imaging; immunostaining; mineralized tissues; primary human MSCs; xenograft

Mesh:

Year:  2019        PMID: 30848692      PMCID: PMC6542146          DOI: 10.1369/0022155419836436

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  31 in total

1.  Histological analysis of GFP expression in murine bone.

Authors:  Xi Jiang; Zana Kalajzic; Peter Maye; Alen Braut; Justin Bellizzi; Mina Mina; David W Rowe
Journal:  J Histochem Cytochem       Date:  2005-05       Impact factor: 2.479

Review 2.  Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF).

Authors:  David M Dohan Ehrenfest; Lars Rasmusson; Tomas Albrektsson
Journal:  Trends Biotechnol       Date:  2009-01-31       Impact factor: 19.536

3.  In vitro expansion of human mesenchymal stem cells: choice of serum is a determinant of cell proliferation, differentiation, gene expression, and transcriptome stability.

Authors:  Aboulghassem Shahdadfar; Katrine Frønsdal; Terje Haug; Finn P Reinholt; Jan E Brinchmann
Journal:  Stem Cells       Date:  2005-08-04       Impact factor: 6.277

4.  AML xenograft efficiency is significantly improved in NOD/SCID-IL2RG mice constitutively expressing human SCF, GM-CSF and IL-3.

Authors:  M Wunderlich; F-S Chou; K A Link; B Mizukawa; R L Perry; M Carroll; J C Mulloy
Journal:  Leukemia       Date:  2010-08-05       Impact factor: 11.528

5.  Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors.

Authors:  Carlos Lois; Elizabeth J Hong; Shirley Pease; Eric J Brown; David Baltimore
Journal:  Science       Date:  2002-01-10       Impact factor: 47.728

6.  Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment.

Authors:  Benedetto Sacchetti; Alessia Funari; Stefano Michienzi; Silvia Di Cesare; Stefania Piersanti; Isabella Saggio; Enrico Tagliafico; Stefano Ferrari; Pamela Gehron Robey; Mara Riminucci; Paolo Bianco
Journal:  Cell       Date:  2007-10-19       Impact factor: 41.582

Review 7.  Bone regeneration and repair.

Authors:  Nicholas J Panetta; Deepak M Gupta; Michael T Longaker
Journal:  Curr Stem Cell Res Ther       Date:  2010-06       Impact factor: 3.828

Review 8.  Bone marrow stromal cells (BMSCs) in bone engineering: limitations and recent advances.

Authors:  Anna R Derubeis; Ranieri Cancedda
Journal:  Ann Biomed Eng       Date:  2004-01       Impact factor: 3.934

9.  Denosumab, a fully human monoclonal antibody to RANKL, inhibits bone resorption and increases BMD in knock-in mice that express chimeric (murine/human) RANKL.

Authors:  Paul J Kostenuik; Hung Q Nguyen; James McCabe; Kelly S Warmington; Carol Kurahara; Ning Sun; Ching Chen; Luke Li; Russ C Cattley; Gwyneth Van; Shelia Scully; Robin Elliott; Mario Grisanti; Sean Morony; Hong Lin Tan; Frank Asuncion; Xiaodong Li; Michael S Ominsky; Marina Stolina; Denise Dwyer; William C Dougall; Nessa Hawkins; William J Boyle; William S Simonet; John K Sullivan
Journal:  J Bone Miner Res       Date:  2009-02       Impact factor: 6.741

10.  Orthotopic bone formation in titanium fiber mesh loaded with platelet-rich plasma and placed in segmental defects.

Authors:  H C Kroese-Deutman; J W M Vehof; P H M Spauwen; P J W Stoelinga; J A Jansen
Journal:  Int J Oral Maxillofac Surg       Date:  2008-03-05       Impact factor: 2.789

View more
  3 in total

1.  Evaluation of an Engineered Hybrid Matrix for Bone Regeneration via Endochondral Ossification.

Authors:  Paiyz E Mikael; Aleksandra A Golebiowska; Xiaonan Xin; David W Rowe; Syam P Nukavarapu
Journal:  Ann Biomed Eng       Date:  2019-04-29       Impact factor: 3.934

2.  Human amniotic fluid stem cells attract osteoprogenitor cells in bone healing.

Authors:  Mariangela Basile; Francesco Marchegiani; Sanja Novak; Ivo Kalajzic; Roberta Di Pietro
Journal:  J Cell Physiol       Date:  2019-10-24       Impact factor: 6.384

3.  Senolytics improve bone forming potential of bone marrow mesenchymal stem cells from aged mice.

Authors:  Yueying Zhou; Xiaonan Xin; Lichao Wang; Binsheng Wang; Li Chen; Ousheng Liu; David W Rowe; Ming Xu
Journal:  NPJ Regen Med       Date:  2021-06-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.